(6-(2,2,2-Trifluoroethoxy)pyridin-3-yl)methanamine hydrochloride → 6-methyl-2-(oxazol-2-ylamino)-N-((6-(2,2,2-trifluoroethoxy)pyridin-3-yl)methyl)pyrimidine-4-carboxamide
Reaction equation
[CH3:1][C:2]1[N:7]=[C:6]([NH:8][C:9]2[O:10][CH:11]=[CH:12][N:13]=2)[N:5]=[C:4]([C:14]([OH:16])=O)[CH:3]=1.Cl.[F:18][C:19]([F:31])([F:30])[CH2:20][O:21][C:22]1[N:27]=[CH:26][C:25]([CH2:28][NH2:29])=[CH:24][CH:23]=1>>[CH3:1][C:2]1[N:7]=[C:6]([NH:8][C:9]2[O:10][CH:11]=[CH:12][N:13]=2)[N:5]=[C:4]([C:14]([NH:29][CH2:28][C:25]2[CH:26]=[N:27][C:22]([O:21][CH2:20][C:19]([F:31])([F:18])[F:30])=[CH:23][CH:24]=2)=[O:16])[CH:3]=1Participants
3
Procedure
The title compound is prepared from 6-methyl-2-(oxazol-2-ylamino)pyrimidine-4-carboxylic acid (25 mg, 0.11 mmol, Step-1) and (6-(2,2,2-trifluoroethoxy)pyridin-3-yl)methanamine hydrochloride (28 mg, 0.11 mmol) by the similar manner in Example-2.
Sources & evidence
- ORD record
- ord-3d7f2b2bd599460ea7242ec3fc99fe3e
- Source dataset
- uspto-grants-2016_04
- Patent number
- US09302991B2
Reaction notes
Loading…